Immediate Impact

1 from Science/Nature 60 hit
Sub-graph 1 of 22

Citing Papers

Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2025 Hit
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial
2025 Hit
3 intermediate papers

Works of Lyn D Ferguson being referenced

Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions
2020
Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease
2019

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lyn D Ferguson 205 199 137 135 133 36 824
Arjan J. Kwakernaak 230 1.1× 181 0.9× 168 1.2× 87 0.6× 185 1.4× 44 984
Haiyu Pang 173 0.8× 67 0.3× 135 1.0× 169 1.3× 141 1.1× 50 882
Jing Cao 340 1.7× 183 0.9× 42 0.3× 83 0.6× 182 1.4× 52 973
Lior Zeller 226 1.1× 169 0.8× 46 0.3× 200 1.5× 142 1.1× 45 858
Haralambos Milionis 309 1.5× 172 0.9× 90 0.7× 225 1.7× 265 2.0× 29 1.0k
Ruiqi Zhang 174 0.8× 212 1.1× 147 1.1× 82 0.6× 414 3.1× 29 877
Αθανάσιος Παπαθανασίου 233 1.1× 112 0.6× 77 0.6× 135 1.0× 227 1.7× 61 975
Iacopo Cricelli 123 0.6× 110 0.6× 127 0.9× 136 1.0× 96 0.7× 42 821
Samir Mallat 154 0.8× 66 0.3× 57 0.4× 151 1.1× 154 1.2× 41 907
Dan-Yu Lin 168 0.8× 86 0.4× 164 1.2× 175 1.3× 224 1.7× 22 842

All Works

Loading papers...

Rankless by CCL
2026